Olfactory loss as a supporting feature in the diagnosis of Parkinson's disease: A pragmatic approach

Journal of Neurology

Volumn 260, Issue 12, 2013, Pages 2951-2958

  Hoyles, Katie ^a   Sharma, Jagdish C ^a,b  

^a LINCOLN COUNTY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Diagnosis; Olfaction; Parkinson's disease

Indexed keywords

DOPAMINE TRANSPORTER; LEVODOPA;

ALZHEIMER DISEASE; CLINICAL FEATURE; COGNITIVE DEFECT; CORTICOBASAL DEGENERATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; DISEASE DURATION; DRUG INDUCED DISEASE; DRUG INDUCED PARKINSONISM; ESSENTIAL TREMOR; HUMAN; MULTIINFARCT DEMENTIA; NEUROIMAGING; NEUROPATHOLOGY; OLFACTORY SYSTEM; PARKINSON DISEASE; PARKINSONISM; PHOTON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; SCREENING TEST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMELLING DISORDER;

HUMANS; OLFACTION DISORDERS; PARKINSON DISEASE;

EID: 84890790952     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-013-6848-8     Document Type: Review

References (70)

1. Gaig C, Tolosa E (2009) When does Parkinson's disease begin? Mov Disord 24(Suppl 2):S656-S664
2. Politis M, Wu K, Molloy S, GB P, Chaudhuri KR, Piccini P (2010) Parkinson's disease symptoms: the patient's perspective. Mov Disord 25(11):1646-1651
3. Ansari KA, Johnson A (1975) Olfactory function in patients with Parkinson's disease. J Chronic Dis 28(9):493-497
4. Murphy C, Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM (2002) Prevalence of olfactory impairment in older adults. JAMA 288(18):2307-2312
5. Doty RL, Deems DA, Stellar S (1988) Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38(8):1237-1244
6. Haehner A, Boesveldt S, Berendse HW, Mackay-Sim A, Fleischmann J, Silburn PA et al (2009) Prevalence of smell loss in Parkinson's disease-a multicenter study. Parkinsonism Relat Disord 15(7):490-494
7. Hawkes CH (2008) Parkinson's disease and aging: same or different process? Mov Disord 23(1):47-53
8. Louis ED, Marder K, Tabert MH, Devanand DP (2008) Mild parkinsonian signs are associated with lower olfactory test score in the community-dwelling elderly. Mov Disord 15:524-530
9. Sharma JC, Turton J (2012) Olfaction, dyskinesia and profile of weight change in Parkinson's disease: identifying neurodegenerative phenotypes. Parkinsonism Relat Disord 18:946-970
10. Berendse HW, Roos DS, Raijmakers P, Doty RL (2011) Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease. J Neurol Sci 310:21-24
11. Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI (1992) Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 55(2):138-142
12. Hawkes CH, Shephard BC, Daniel SE (1997) Olfactory dysfunction in Parkinson's disease. J Neurol Neurosurg Psychiatry 62(5):436-446
13. Meusel T, Westermann B, Fuhr P, Hummel T, Welge-Lussen A (2010) The course of olfactory deficits in patients with Parkinson's disease-a study based on psychophysical and electrophysiological measures. Neurosci Lett 486(3):166-170
14. Herting B, Schulze S, Reichmann H, Haehner A, Hummel T (2008) A longitudinal study of olfactory function in patients with idiopathic Parkinson's disease. J Neurol 255(3):367-370
15. Morley JF, Duda JE (2010) Olfaction as a biomarker in Parkinson's disease. Biomark Med 4(5):661-670
16. Pearce RK, Hawkes CH, Daniel SE (1995) The anterior olfactory nucleus in Parkinson's disease. Mov Disord 10(3):283-287
17. Ross GW, Abbott RD, Petrovitch H, Tanner CM, White LR (2012) Pre-motor features of Parkinson's disease: the Honolulu-Asia aging study experience. Parkinsonism Relat Disord 18(Suppl 1):S199-S202
18. Stern MB, Doty RL, Dotti M, Corcoran P, Crawford D, McKeown DA et al (1994) Olfactory function in Parkinson's disease subtypes. Neurology 44(2):266-268
19. Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters E, Berendse HW (2004) Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 56(2):173-181
20. Ponsen MM, Stoffers D, Twisk JW, Wolters E, Berendse HW (2009) Hyposmia and executive dysfunction as predictors of future Parkinson's disease: a prospective study. Mov Disord 24(7):1060-1065
21. Ponsen MM, Stoffers D, Wolters E, Booij J, Berendse HW (2010) Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease. J Neurol Neurosurg Psychiatry 81(4):396-399
22. Sherwood L (2007) Human physiology from cells to systems, 6th edn. Thomson Brooks/Cole, Belmont
23. Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rub U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J Neurol 249 (Suppl 3): III/1-5
24. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24(2):197-211
25. Silveira-Moriyama L, Holton JL, Kingsbury A, Ayling H, Petrie A, Sterlacci W et al (2009) Regional differences in the severity of Lewy body pathology across the olfactory cortex. Neurosci Lett 453(2):77-80
26. Mundinano IC, Caballero MC, Ordonez C, Hernandez M, DiCaudo C, Marcilla I et al (2011) Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders. Acta Neuropathol 122(1):61-74
27. Sharma JC, Butcher C (2012) Asymmetry of Olfactory sulcus depth and relationship with olfaction in Parkinson's disease. European Federation of Neurological Societies, Stockholm
28. Witt M, Bormann K, Gudziol V, Pehlke K, Barth K, Minovi A et al (2009) Biopsies of olfactory epithelium in patients with Parkinson's disease. Mov Disord 24(6):906-914
29. Wang J, You H, Liu JF, Ni DF, Zhang ZX, Guan J (2011) Association of olfactory bulb volume and olfactory sulcus depth with olfactory function in patients with Parkinson disease. AJNR Am J Neuroradiol 32(4):677-681
30. Wattendorf E, Welge-Lussen A, Fiedler K, Bilecen D, Wolfensberger M, Fuhr P et al (2009) Olfactory impairment predicts brain atrophy in Parkinson's disease. J Neurosci 29(49):15410-15413
31. Muller A, Reichmann H, Livermore A, Hummel T (2002) Olfactory function in idiopathic Parkinson's disease (IPD): results from cross-sectional studies in IPD patients and long-term follow-up of de-novo IPD patients. J Neural Trans 109(5-6):805-811
32. Roth J, Radil T, Ruzicka E, Jech R, Tichy J (1998) Apomorphine does not influence olfactory thresholds in Parkinson's disease. Funct Neurol 13(2):99-103
33. Bohnen NI, Muller ML, Kotagal V, Koeppe RA, Kilbourn MA, Albin RL et al (2010) Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease. Brain 133(Pt 6):1747-1754
34. Wilson RS, Yu L, Schneider JA, Arnold SE, Buchman AS, Bennett DA (2011) Lewy bodies and olfactory dysfunction in old age. Chem Senses 36(4):367-373
35. Hawkes CH, Del Tredici K, Braak H (2009) Parkinson's disease: the dual hit theory revisited. Ann N Y Acad Sci 1170:615-622
36. Doty RL, Shaman P, Kimmelman CP, Dann MS (1984) University of Pennsylvania Smell identification test: a rapid quantitative olfactory function test for the clinic. Laryngoscope 94(2 Pt 1):176-178
37. Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G (1997) 'Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 22(1):39-52
38. Daum RF, Sekinger B, Kobal G, Lang CJ (2000) Olfactory testing with "sniffin' sticks" for clinical diagnosis of Parkinson disease. Nervenarzt 71(8):643-650
39. Welge-Lussen A, Wattendorf E, Schwerdtfeger U, Fuhr P, Bilecen D, Hummel T et al (2009) Olfactory-induced brain activity in Parkinson's disease relates to the expression of event-related potentials: a functional magnetic resonance imaging study. Neuroscience 162(2):537-543
40. Silveira-Moriyama L, Schwingenschuh P, O'Donnell A, Schneider SA, Mir P, Carrillo F et al (2009) Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs). J Neurol Neurosurg Psychiatry 80(7):744-748
41. Stiasny-Kolster K, Doerr Y, Moller JC, Hoffken H, Behr TM, Oertel WH et al (2005) Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 128(Pt 1):126-137
42. Rolheiser TM, Fulton HG, Good KP, Fisk JD, McKelvey JR, Scherfler C et al (2011) Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson's disease. J Neurol 258(7):1254-1260
43. Winkler J, Ehret R, Buttner T, Dillmann U, Fogel W, Sabolek M et al (2011) Parkinson's disease risk score: moving to a premotor diagnosis. J Neurol 258(Suppl 2):S311-S315
44. Berendse HW, Booij J, Stoffers D, Ponsen MM, Hijman R, Wolters E (2002) Presymptomatic detection of Parkinson's disease. Tijdschr Gerontol Geriatr 33(2):70-77
45. Siderowf A, Jennings D, Eberly S, Oakes D, Hawkins KA, Ascherio A, et al (2012) Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome study. Mov Disord 27:406-412
46. Iijima M, Osawa M, Momose M, Kobayakawa T, Saito S, Iwata M et al (2010) Cardiac sympathetic degeneration correlates with olfactory function in Parkinson's disease. Mov Disord 25(9):1143-1149
47. Oka H, Toyoda C, Yogo M, Mochio S (2010) Olfactory dysfunction and cardiovascular dysautonomia in Parkinson's disease. J Neurol 257(6):969-976
48. Stephenson R, Houghton D, Sundarararjan S, Doty RL, Stern M, Xie SX et al (2010) Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease. Mov Disord 25(13):2099-2104
49. Cramer CK, Friedman JH, Amick MM (2010) Olfaction and apathy in Parkinson's disease. Parkinsonism Relat Disord 16(2):124-126
50. Imamura K, Matumoto S, Mabuchi N, Kobayashi Y, Okayasu N, Watanabe K (2011) Relationship between the regional cerebral blood flow and the cognitive function and anosmia in patients with Parkinson disease and Alzheimer disease. Brain Nerve 61(6):683-690
51. Baba T, Takeda A, Kikuchi A, Nishio Y, Hosokai Y, Hirayama K et al (2011) Association of olfactory dysfunction and brain. Metabolism in Parkinson's disease. Mov Disord 26(4):621-628
52. Morley JF, Weintraub D, Mamikonyan E, Moberg PJ, Siderowf AD, Duda JE (2011) Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease. Mov Disord 26(11):2051-2057
53. Deeb J, Shah M, Muhammed N, Gunasekera R, Gannon K, Findley LJ, Hawkes CH (2012) A basic smell test is as sensitive as a dopamine transporter scan: comparison of olfaction, taste and DaTSCAN in the diagnosis of Parkinson's disease. QJM 103:941-952
54. Gray AJ, Staples V, Murren K, Dhariwal A, Bentham P (2001) Olfactory identification is impaired in clinic-based patients with vascular dementia and senile dementia of Alzheimer's type. Int J Geriatr Psychiatry 16:513-517
55. Olichney JM, Murphy C, Hofstetter CR, Foster K, Hansen LA, Thal LJ, Katzman R (2005) Anosmia id very commom in Lewy body variant of Alzheimer's disease. J Neurol Neurosurg Psychiatry 76:1342-1347
56. Liberini P, Parola S, Spano PF, Antonini L (2000) Olfaction in Parkinson's disease: methods of assessment and clinical relevance. J Neurol 247(2):88-96
57. Doty RL, Golbe LI, McKeown DA, Stern MB, Lehrach CM, Crawford D (1993) Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease. Neurology 43(5):962-965
58. Muller A, Mungersdorf M, Reichmann H, Strehle G, Hummel T (2002) Olfactory function in Parkinsonian syndromes. J Clin Neurosci 9(5):521-524
59. Tsuboi Y, Wszolek ZK, Graff-Radford NR, Cookson N, Dickson DW (2003) Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4. Neuropathol Appl Neurobiol 29(5):503-510
60. Katzenschlager R, Zijlmans J, Evans A, Watt H, Lees AJ (2004) Olfactory function distinguishes vascular parkinsonism from Parkinson's disease. J Neurol Neurosurg Psychiatry 75(12):1749-1752
61. Shah M, Muhammed N, Findley LJ, Hawkes CH (2008) Olfactory tests in the diagnosis of essential tremor. Parkinsonism Relat Disord 14(7):563-568
62. Bovi T, Antonini A, Ottaviani S, Antonioli A, Cecchini MP, Di Francesco V et al (2010) The status of olfactory function and the striatal dopaminergic system in drug-induced parkinsonism. J Neurol 257(11):1882-1889
63. Hensiek A, Bhatia K, Hawkes C (2000) Olfactory function in drug-induced parkinsonism. J Neurol 247(82):303
64. Doty RL, Singh A, Tetrud J, Langston JW (1992) Lack of major olfactory dysfunction in MPTP-induced parkinsonism. Ann Neurol 32(1):97-100
65. Iijima M, Kobayakawa T, Saito S, Osawa M, Tsutsumi Y, Hashimoto S et al (2010) Differences in odor identification among clinical subtypes of Parkinson's disease. Eur J Neurol 18(3):425-429
66. Suchowersky O et al (2006) Practice patameter: diagnosis and prognosis of new onset Parkinson's disease (an evidence based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 66:968-975
67. Wenning GK, Shephard B, Hawkes C, Petruckevitch A, Lees A, Quinn N (1995) Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand 91(4):247-250
68. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181-184
69. Varrone A, Marek KL, Jennings D, Innis RB, Seibyl JP (2001) [123I]ß-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy. Mov Disord 16:1023-1032
70. Schreckenberger M, Hägele S, Siessmeier T et al (2004) The dopamine D2 receptor ligand 18F-desmethoxyfallypride: an appropriate fluorinated PET tracer for the differential diagnosis of parkinsonism. Eur J Nucl Med Mol Imaging 31:1128-1135